glp-1 autism Ozempic Pill May Come With a Hidden Downside, Experts Warn GLP-1 Genetics: How Genes Affect

Oxidative stress status and sperm DNA fragmentation in fertile and infertile men

Liver fibrosis and liver stiffness in patients with obesity and type 1 diabetes

According to a Rybelsus trial published in the The New England Journal of Medicine: 44% of users reported nausea 32% of users reported diarrhea Key takeaway Early evidence showed that Pfizers new oral GLP-1 receptor agonist danuglipron showed similar results to Novos Ozempic without the need for injection, and to its oral formulation Rybelsus without the need for fasting restrictions

The result is that patients eat less, feel full faster, and lose weight at a rate that exceeds most other pharmacological interventions

The peptide itself is identical to what's used in injectable form